H. Lundbeck A/S today announced the initiation of the first Japanese clinical phase II trial with desmoteplase (DIAS-J) in the treatment of acute ischaemic stroke. This study is required for the approval of the substance for the Japanese market. In 2009 Lundbeck successfully performed a phase I study in around 30 healthy Japanese volunteers with [...]
Desmoteplase enters clinical phase II in Japan in ischaemic stroke
H. Lundbeck A/S today announced the initiation of the first Japanese clinical phase II trial with desmoteplase (DIAS-J) in the treatment of acute ischaemic stroke. This study is required for the approval of the substance ...
H. Lundbeck A/S today announced the initiation of the first Japanese clinical phase II trial with desmoteplase (DIAS-J) in the treatment of acute ischaemic stroke. This study is required for the approval of the substance ...
Basilea’s antifungal isavuconazole passed phase III clinical trial futility analysis
Basilea Pharmaceutica Ltd. announced that based on a futility analysis of the isavuconazole phase III trial for the treatment of invasive Aspergillus infections, the Independent Data Safety Monitoring Board (IDSMB) has recommended the continuation of ...
Basilea Pharmaceutica Ltd. announced that based on a futility analysis of the isavuconazole phase III trial for the treatment of invasive Aspergillus infections, the Independent Data Safety Monitoring Board (IDSMB) has recommended the continuation of ...
Catheter-Based Device for Mitral Valve Repair from Abbott
Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system met both its primary ...
Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system met both its primary ...
72% of doctors surveyed agree that employers should play a role in the health of their employees with chronic conditions
To better understand and improve the effectiveness of employer-based health improvement and management programs, the Midwest Business Group on Health (MBGH), conducted a national survey of physician views on employers' health management programs. The non-profit ...
To better understand and improve the effectiveness of employer-based health improvement and management programs, the Midwest Business Group on Health (MBGH), conducted a national survey of physician views on employers' health management programs. The non-profit ...
‘Controlled crying’ technique safe for babies
Using behavioural techniques including ‘controlled crying’ to help infants sleep does not lead to later emotional and behavioural problems, according to new research by the Murdoch Childrens Research Institute. The world-first study followed up 225 six-year-old ...
Using behavioural techniques including ‘controlled crying’ to help infants sleep does not lead to later emotional and behavioural problems, according to new research by the Murdoch Childrens Research Institute. The world-first study followed up 225 six-year-old ...
Vacc-C5 to be prepared for phase I/II clinical trial
Based on results from pre-clinical research, Nutri Pharma ASA's wholly owned subsidiary Bionor Immuno AS, has today announced that it will take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 towards phase I/II clinical trial. Research ...
Based on results from pre-clinical research, Nutri Pharma ASA's wholly owned subsidiary Bionor Immuno AS, has today announced that it will take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 towards phase I/II clinical trial. Research ...
